-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $399

Benzinga·04/24/2026 14:58:14
Listen to the news
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $396 to $399.